Natural gas is the primary feedstock for methane chlorination. When Chinese industrial gas prices rise - typically driven by winter heating demand, LNG import costs, or domestic supply constraints - DCM production costs rise correspondingly. The 2021–2022 global gas price spike, driven by post-COVID demand recovery and the Ukraine conflict, pushed DCM production costs to multi-year highs.

Chlorine availability and cost is determined by chlor-alkali operating rates, which in turn are driven by caustic soda demand from alumina refining, pulp and paper, and chemical industries. When Chinese chlor-alkali plants operate at high utilisation, chlorine is abundant and cheap, benefiting DCM producers. Operating rate cuts tighten chlorine supply and raise DCM costs.

Since 2015, China's Ministry of Ecology and Environment has conducted periodic "Blue Sky" campaigns targeting VOC emissions from chemical plants, including DCM producers. Production curtailments during inspection periods can rapidly tighten supply and spike spot prices by 15–30% within weeks. These events are often unpredictable and create the most abrupt price movements in the DCM market.

DCM demand reflects activity in its end-use markets: pharmaceutical production (relatively stable, growing), paint and coating removal (seasonal - stronger in spring/summer construction season), agrochemical manufacturing (seasonal - tied to planting cycles), and industrial cleaning (linked to manufacturing activity indices). Demand typically peaks Q2–Q3 in the Northern Hemisphere.

US and EU paint-stripping bans have structurally reduced DCM demand in these high-value markets. This demand destruction has partly offset the growth from pharmaceutical and agrochemical sectors. Future restrictions on additional end uses (industrial degreasing, other applications under EPA TSCA review) could further reduce demand, creating persistent oversupply pressure despite supply-side constraints.

DCM is predominantly priced in USD for international trade, while Chinese production costs are denominated in CNY. A weaker CNY (more yuan per dollar) makes Chinese exports cheaper in USD terms, potentially depressing international prices. A stronger CNY raises export prices. The USD/CNY rate is therefore a silent but consistent factor in the competitiveness of Chinese DCM on global markets.

China accounts for roughly 60–70% of global DCM production capacity and is the dominant price-setter for international markets. Domestic ex-works prices in Shandong and Jiangsu (the main production provinces) serve as the de facto reference point for all Asian export pricing. Domestic Chinese prices are often 10–20% below export FOB prices due to local supply abundance and the exclusion of export logistics costs.

India is among the largest importers of Chinese DCM, driven by demand from its large pharmaceutical, agrochemical, and textile industries. Indian buyers typically source on CIF terms with pricing referenced to Chinese FOB plus freight (approx. USD 30–60/MT for sea freight from Chinese ports to Nhava Sheva / Chennai). Import duty is typically around 7.5%, adding to landed cost.

European DCM prices command a significant premium over Chinese FOB - typically USD 150–250/MT above Chinese equivalents, reflecting REACH compliance costs, longer supply chains, and local production (INEOS, Dow Chemical in Europe) meeting demand for regulated grades. Regulatory restrictions have reduced European DCM volumes, particularly for paint stripping, shifting the market toward higher-value pharmaceutical and extraction uses.

The US Section 301 tariff of 25% on Chinese DCM (HS 2903.12) has significantly reduced Chinese DCM imports into the US market since 2018. US buyers increasingly source from domestic producers (Olin Corporation, Occidental Chemical) or from non-Chinese origins (Mexico, South Korea) to avoid the tariff surcharge. For buyers who must source Chinese DCM into the US, the 25% tariff represents a substantial landed cost premium.

Southeast Asia and the Middle East represent the fastest-growing import markets for Chinese DCM. Driven by expanding pharmaceutical manufacturing (Indonesia, Vietnam, Malaysia), agrochemical production (Thailand, India pipeline), and petrochemical growth (Saudi Arabia, UAE), these markets absorb significant Chinese DCM exports at competitive FOB plus modest freight premiums. No significant import duties or restrictions on DCM apply in most of these markets.

Q1: What is the current price of DCM, and where can I track it?

DCM market prices are not publicly reported with the frequency of major commodity chemicals like ethylene or benzene. Indicative price ranges are published by ICIS, ChemAnalyst, and Asian Chemical Reporter on a subscription basis. For real-time transaction prices, direct enquiry to multiple suppliers is the most reliable approach. As a broad benchmark for 2024–2025, technical grade DCM from China has traded in the approximate range of USD 360–500/MT FOB, but this varies significantly with volume, grade, and market conditions. Contact Sinolook Chemical for current pricing specific to your grade, volume, and destination.

Q2: Why do DCM prices spike so suddenly sometimes?

The most common cause of sudden DCM price spikes is Chinese environmental inspection campaigns that curtail production at multiple facilities simultaneously. These inspections can reduce available supply by 20–40% within days, while demand responds more slowly, creating a sharp but often temporary supply squeeze. Secondary causes include sudden increases in feedstock costs (particularly natural gas), logistics disruptions affecting export availability, and currency movements. These spikes typically last 4–12 weeks before capacity that has not been shut down (or restarted capacity) restores the supply-demand balance.

Q3: How much does pharmaceutical grade cost compared to technical grade DCM?

Pharmaceutical grade DCM (≥99.9% GC purity, chloroform ≤10 ppm, water ≤30 ppm) typically commands a premium of USD 50–150/MT above technical grade (≥99.0–99.5%), depending on volume and documentation requirements. The premium reflects additional distillation steps to reduce chloroform content, stricter QC testing and batch documentation, stability data requirements, and the lower production volumes relative to technical grade. For small pharmaceutical buyers purchasing in drum quantities with full COA and ICH Q3C documentation support, the premium toward the higher end of this range is typical.

Q4: Does the US Section 301 tariff apply to all DCM imports from China?

The Section 301 tariff (currently 25%) applies to DCM classified under HTS 2903.12.00 imported from China into the United States. This covers virtually all commercial DCM grades. Some buyers have explored tariff engineering routes (transshipment through third countries) but these carry significant legal risk under US customs law and are generally not advisable. US buyers should factor the 25% tariff into their total landed cost analysis when comparing Chinese DCM against domestic US production (Olin, Occidental Chemical) or non-China-origin alternatives. Always verify the current tariff rate with a licensed US customs broker, as Section 301 rates have been subject to review and modification.

Q5: Will DCM prices rise or fall over the next 2–3 years?

The medium-term DCM price outlook is shaped by opposing forces: (1) Upward pressure from rising environmental compliance costs at Chinese producers, potential tightening of Chinese VOC regulations, and pharmaceutical demand growth; (2) Downward pressure from continued Chinese capacity abundance, demand destruction from US/EU regulatory restrictions on paint-stripping and potentially other uses, and substitution of DCM by greener solvents in pharmaceutical and industrial applications. The net effect is likely to be moderate price levels within a USD 350–550/MT FOB range, with volatility driven by the episodic Chinese supply disruptions described above rather than structural trend movements. Regulatory restriction of additional DCM uses in the US (EPA TSCA outcome) is the largest single variable that could shift this outlook toward the lower end.

Q6: How many weeks of DCM safety stock should I hold?

The appropriate safety stock level depends on your supply chain exposure: (1) Buyers sourcing only from Chinese suppliers: Hold 6–8 weeks of safety stock given the episodic supply disruption risk. Chinese inspection campaigns can last 4–6 weeks, and lead time from new orders (including manufacturing, documentation, and sea freight) is typically 5–8 weeks for Asian destinations; (2) Buyers with qualified secondary supplier: 4–6 weeks is adequate if the secondary supplier can deliver within 2–3 weeks; (3) Pharmaceutical buyers: May need 8–12 weeks due to the high cost of production stoppages and the time required to qualify a new supplier batch under GMP. Always maintain safety stock records - auditors may request evidence of supply chain risk management as part of GMP compliance documentation.